The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer-Reference-Cited by-同舟云学术

The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer

Published:2016-09-15 Issue:5 Volume:10 Page:665-671
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Amin Sunil¹,Boffetta Paolo²,Lucas Aimee L.¹

Affiliation:

1. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

2. Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2016/010/ekjg010-05-05.pdf

Reference74 articles.

1. Cancer statistics, 2014

2. Howlader, N, Noone, AM, and Krapcho, M (2013). SEER cancer statistics review (CSR) 1975–2010. Bethesda: National Cancer Institute

3. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

4. Repurposing of Metformin and Aspirin by Targeting AMPK-mTOR and Inflammation for Pancreatic Cancer Prevention and Treatment

5. Coogan, PF, Rosenberg, L, and Palmer, JR (2000). Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol Biomarkers Prev.9, 119-123.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of post-pancreatitis diabetes mellitus: insights from the COSMOS program;Expert Review of Endocrinology & Metabolism;2024-07-22

2. Pathogenic role of 25-hydroxycholesterol in cancer development and progression;Future Oncology;2022-12

3. An Update on Common Pharmaceuticals in the Prevention of Pancreatic Cancer;Cureus;2022-05-30

4. Chemopreventive Effects of Concomitant or Individual Use of Statins, Aspirin, Metformin, and Angiotensin Drugs: A Study Using Claims Data of 23 Million Individuals;Cancers;2022-02-25

5. Bisphosphonate Use Does Not Impact Survival in Patients with Pancreatic Cancer: A Propensity Score Matching Analysis;Gut and Liver;2021-09-15